Onabotulinumtoxina
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Onabotulinumtoxina is used to treat blepharospasm, dystonia, fissure in ano, hyperhidrosis, migraine disorders and muscle rigidity, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $122 million on Onabotulinumtoxina across 90,000 claims for 36,000 beneficiaries.
Onabotulinumtoxina is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $597.52 to $1155.68 per EA — a 93% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$597.52 – $1155.68
per EA
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ONABOTULINUMTOXINA
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
BOTOX 200 UNITS VIAL | $1155.6819 per EA | — |
BOTOX 100 UNITS VIAL | $597.5185 per EA | — |
BOTOX COSMETIC 100 UNITS VIAL | $597.5185 per EA | — |
Frequently Asked Questions
What is Onabotulinumtoxina used to treat?
Onabotulinumtoxina is used to treat blepharospasm, dystonia, fissure in ano, hyperhidrosis, migraine disorders and muscle rigidity, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Onabotulinumtoxina?
In 2024, Medicare Part D spent $122 million on Onabotulinumtoxina across 90,000 claims for 36,000 beneficiaries.
How many Onabotulinumtoxina products are on the market?
The Onabotulinumtoxina drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Onabotulinumtoxina?
NADAC reference prices for Onabotulinumtoxina range from $597.5185 to $1155.6819 per EA — a 93% difference between cheapest and most expensive.
Which manufacturers make Onabotulinumtoxina?
1 manufacturer lists Onabotulinumtoxina in NADAC. Ranked by number of NDCs, the largest are Allergan, Inc. (3).